Testing the Impact of the MOHR Follow-up Support
Testing the Impact of the My Own Health Report Intervention With 3 Distinct Options for Structured Follow-up as Compared to a Control Condition
2 other identifiers
interventional
1,000
1 country
6
Brief Summary
This study will evaluate the impact of 3 different strategies to increase engagement of participants in My Own Health Report (MOHR) and health behavior change activities over time. This study will evaluate the level of engagement, outcomes, cost and cost-effectiveness of these strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2026
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2026
CompletedFirst Submitted
Initial submission to the registry
April 29, 2026
CompletedFirst Posted
Study publicly available on registry
May 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
May 6, 2026
April 1, 2026
3.2 years
April 29, 2026
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number of MOHR risk factors
Primary effectiveness outcome measured on scale from -6 to +6 as change of the number of risk factors improved. MOHR questions are organized into 6 risk areas: 1) intake of fruits and vegetables; 2) high sugar beverages; 3) fast food; 4) physical activity; 5) stress; and 6) sleep. Each risk factor is evaluated as low risk, medium risk, or high risk. Level of improvement in risk factors outcome will be a count score from -6 to 6 (any improvement or decrement in level of risk in each factor will count as 1 or -1).
From enrollment to the follow-up survey timepoint at 2 months.
REACH - specifically representative engagement
Primary implementation outcome. Representative engagement: Engagement during the follow-up period involves interactions over time of the participant with either or both a navigator or text messages . Engagement will be assessed percent of navigator calls completed (maximum of 12 over 6 months) and percent of text messages successfully sent (maximum of 60 over 6 months). To assess whether engagement is representative our primary assessments will be if there is differential engagement across conditions (e.g., an interaction effect) based on 1) number of baseline social needs, 2) Latine vs. non Latine ethnicity or 3) digital literacy.
From enrollment to the follow-up survey timepoint at 6 months.
Patient experience
Primary practice value outcome measured by change in mean score on Patient Assessment of Quality-of-Care subscales of goal setting/tailoring and follow-up/coordination (PACIC). Scale ranges from almost never (indicating the worst patient experience) to almost always (indicating the best patient experience).
From enrollment to the follow up survey time point at 6 months.
Study Arms (4)
Control Arm
ACTIVE COMPARATORStandardized version of usual care
R2 Message Only
EXPERIMENTALReminder and Resources Messages sent to patient
R2 Navigation only
EXPERIMENTALReminder and Resources provided to patient via health navigator
R2 Message + R2 Navigation
EXPERIMENTALBoth reminder and resources messages and navigation provided to the patient
Interventions
Patients will be provided reminders and resources using messages sent to patients.
Regular (standard) care provided by healthcare provider team
Patients will be provided reminders and resources using health navigators calling the patients.
Eligibility Criteria
You may qualify if:
- Adults, aged 18 years and older.
- Completion of the MOHR health risk assessment and goal-setting tool
- Score in the "at-risk" range on both of the following cancer risk assessments: 1) Physical activity risk: less than 150 minutes per week of moderate to vigorous physical activity; Diet risk: Less than 5 servings daily of combined fruit/vegetables
- Patient at one of the participating clinics
You may not qualify if:
- Incomplete or no MOHR assessment
- Language preference/proficiency other than English or Spanish
- Presence of a condition(s) or diagnosis, either physical or psychological, or physical exam finding that precludes participation. Examples include - Indices of advanced illness and frailty, such as dementia (ICD-10 codes F01.50, F01.51, F02.80, F02.81, F03.90, F03.91, F10.27, F10.97, G31.09, G31.83 or dementia medication of Donepezil • Galantamine • Rivastigmine, Memantine, or Donepezil-memantine)).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Cancer Institute (NCI)collaborator
- University of Colorado, Denverlead
Study Sites (6)
University of Colorado Hospital
Aurora, Colorado, 80045, United States
UCHealth Women's Integrated Services in Health (WISH)
Denver, Colorado, 80045, United States
UCHealth Cherry Creek Medical Center
Denver, Colorado, 80206, United States
UCHealth Internal Medical Clinic - Lowry
Denver, Colorado, 80230, United States
UCHealth Lone Tree Medical Center
Lone Tree, Colorado, 80124, United States
UCHealth Family Medicine - Westminster
Westminster, Colorado, 80021, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2026
First Posted
May 6, 2026
Study Start
April 20, 2026
Primary Completion (Estimated)
June 30, 2029
Study Completion (Estimated)
December 31, 2029
Last Updated
May 6, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Due to HIPAA we cannot share IPD from EHR.